RecallDepth
Class II Terminated

Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702 Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches. The foreign packaging do not have NDC numbers

This recall has been terminated (originally issued August 14, 2013).

Company
Novartis Consumer Health
Recall Initiated
June 6, 2013
Posted
August 14, 2013
Recall Number
D-844-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
10,624,000 pouches
Firm Location
Lincoln, NE, United States
Official Source
View on FDA website ↗

Reason for Recall

Defective container: products are packaged in pouches which may not have been fully sealed

Distribution

Nationwide, Puerto Rico, Brazil and Panama

Lot / Code Info

Lot # a) 10116809, Exp 5/13 Foreign: Lot #s b) 10115644 Exp 5/13; 10118226 Exp 5/13; 10118227 Exp 6/13; 10118228 Exp 6/13; 10121956 Exp 8/13 and 10121957 Exp 8/13

More recalls by Novartis Consumer Health

View all recalls by this company →

Other recent Class II Drug recalls